---
title: "European stocks \"Eleven Arhats\" | Novo Nordisk fell more than 11% this week, while parent company of Louis Vuitton, Germany's SAP, and Novartis fell more than 4%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231894463.md"
description: "This week, Novo Nordisk's stock price has fallen by more than 11%, marking a decline for two consecutive weeks. The stock prices of LVMH, SAP, and Novartis have also dropped by more than 4% respectively. ASML Holding's stock price rose by 2.07%, but it has decreased by 1.55% over the week. Other companies such as L'Oréal, Roche Holding, and AstraZeneca have experienced varying degrees of ups and downs"
datetime: "2025-03-14T17:42:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231894463.md)
  - [en](https://longbridge.com/en/news/231894463.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231894463.md)
generator: "portal-rs"
---

# European stocks "Eleven Arhats" | Novo Nordisk fell more than 11% this week, while parent company of Louis Vuitton, Germany's SAP, and Novartis fell more than 4%

On Friday (March 14), ASML Holding's stock price in Amsterdam (ASML.NA) closed up 2.07% at €655.70, with a cumulative decline of 1.55% for the week. Novo Nordisk's stock price in Copenhagen (NOVOB.DC) closed up 0.99% at 530.20 Danish Krone, with a cumulative decline of 11.28% for the week, marking the second consecutive week of decline. L'Oréal (OR.FP) closed up 3.40%, with a cumulative increase of 2.04% for the week; SAP (SAP.GR) closed up 2.41%, with a cumulative decline of 4.31% for the week; Roche Holding (ROG.SW) closed up 0.99%, with a cumulative decline of 0.39% for the week; AstraZeneca (AZN.LN) closed up 0.94%, with a cumulative decline of 0.65% for the week; GlaxoSmithKline's stock price in London (GSK.LN) closed up 0.80%, with a cumulative decline of 1.47% for the week; LVMH Group (MC.FP) closed up 0.02%, with a cumulative decline of 4.66% for the week; Sanofi (SAN.FP) closed flat, with a cumulative decline of 3.10% for the week; Nestlé (NESN.SW) closed down 0.07%, with a cumulative decline of 0.60% for the week; Novartis (NOVN.SW) closed down 0.60%, with a cumulative decline of 4.60% for the week

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [SAP.US](https://longbridge.com/en/quote/SAP.US.md)
- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [ASML.US](https://longbridge.com/en/quote/ASML.US.md)
- [LRLCY.US](https://longbridge.com/en/quote/LRLCY.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [NSRGF.US](https://longbridge.com/en/quote/NSRGF.US.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [LVMUY.US](https://longbridge.com/en/quote/LVMUY.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [NSRGY.US](https://longbridge.com/en/quote/NSRGY.US.md)

## Related News & Research

- [Novartis: More pain on the way?](https://longbridge.com/en/news/298774732.md)
- [Novartis stock tanks following third major pipeline setback](https://longbridge.com/en/news/298340456.md)
- [Key facts: Novartis posts late-stage failures; keeps 5-6% CAGR](https://longbridge.com/en/news/298276336.md)
- [Novartis DM1 Trial Setback Offset by Progress in Neuromuscular Pipeline](https://longbridge.com/en/news/298303140.md)
- [BREAKINGVIEWS-For Novartis, M&A is both a disease and cure](https://longbridge.com/en/news/298726698.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**